AstraZeneca’s Initial Application for Lupus Injection Turned Down by FDA

Saphnelo as an intravenous infusion is approved and commercially available AstraZenecaAZN-2.05%decrease; red down pointing triangle said the U.S. Food and Drug Administration rejected an initial submission for its Saphnelo lupus drug in injection form, and vowed to work with the regulator to move …

Read more on wsj.com

• Lupus
• FDA
• Business
• U.S. Dept. of Health
• U.S. Government